Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study

BACKGROUND: Little is known concerning the degree to which initiation of sildenafil for pulmonary arterial hypertension (PAH) impacts patterns of healthcare utilization and costs. METHODS: Using a large US health insurance claims database, we identified all patients with evidence of PAH (ICD-9-CM di...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Ariel, Edelsberg, John, Teal, Simon, Mychaskiw, Marko A, Oster, Gerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533843/
https://www.ncbi.nlm.nih.gov/pubmed/23231890
http://dx.doi.org/10.1186/1471-2466-12-75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533843/
https://www.ncbi.nlm.nih.gov/pubmed/23231890
http://dx.doi.org/10.1186/1471-2466-12-75

Ejemplares similares